Colistin and its role in the Era of antibiotic resistance: an extended review (2000–2019)

References

• Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005;40(9):1333–1341.
   PubMed Web of Science ®Google Scholar
• Sun J, Zhang H, Liu YH, et al. Towards understanding MCR-like colistin resistance. Trends Microbiol. 2018;26(9):794–808.
   PubMed Web of Science ®Google Scholar
• Jeannot K, Bolard A, Plesiat P. Resistance to polymyxins in Gram-negative organisms. Int J Antimicrob Agents. 2017;49(5):526–535.
   PubMed Web of Science ®Google Scholar
• Srinivas P, Rivard K. Polymyxin resistance in Gram-negative pathogens. Curr Infect Dis Rep. 2017;19(11):38.
   PubMed Web of Science ®Google Scholar
• Sherry N, Howden B. Emerging Gram negative resistance to last-line antimicrobial agents fosfomycin, colistin and ceftazidime-avibactam - epidemiology, laboratory detection and treatment implications. Expert Rev Anti Infect Ther. 2018;16(4):289–306.
   PubMed Web of Science ®Google Scholar
• Velkov T, Roberts KD, Nation RL, et al. Pharmacology of polymyxins: new insights into an ‘old’ class of antibiotics. Future Microbiol. 2013;8(6):711–724.
   PubMed Web of Science ®Google Scholar
• Talbot GH, Bradley J, Edwards JE, Jr., et al. Bad bugs need drugs: an update on the development pipeline from the antimicrobial availability task force of the infectious diseases society of America. Clin Infect Dis. 2006;42(5):657–668.
   PubMed Web of Science ®Google Scholar
• Bialvaei AZ, Samadi KH. Colistin, mechanisms and prevalence of resistance. Curr Med Res Opin. 2015;31(4):707–721.
   PubMed Web of Science ®Google Scholar
• Lim LM, Ly N, Anderson D, et al. Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing. Pharmacotherapy. 2010;30(12):1279–1291.
   PubMed Web of Science ®Google Scholar
• Dijkmans AC, Wilms EB, Kamerling IM, et al. Colistin: revival of an old polymyxin antibiotic. Ther Drug Monit. 2015;37(4):419–427.
   PubMed Web of Science ®Google Scholar
• Son SJ, Huang R, Squire CJ, et al. MCR-1: a promising target for structure-based design of inhibitors to tackle polymyxin resistance. Drug Discov Today. 2019;24(1):206–216.
   PubMed Web of Science ®Google Scholar
• Koyama Y. A new antibiotic “colistin” produced by spore-forming soil bacteria. J Antibiot. 1950 1950;3:457–458.
   Google Scholar
• Kaye KS, Pogue JM, Tran TB, et al. Agents of last resort: polymyxin resistance. Infect Dis Clin North Am. 2016;30(2):391–414.
   PubMed Web of Science ®Google Scholar
• Falagas ME, Rafailidis PI, Matthaiou DK. Resistance to polymyxins: mechanisms, frequency and treatment options. Drug Resist Updat. 2010;13(4–5):132–138.
   PubMed Web of Science ®Google Scholar
• Gurjar M. Colistin for lung infection: an update. J Intensive Care. 2015;3(1):3.
   PubMedGoogle Scholar
• Li J, Nation RL, Milne RW, et al. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int J Antimicrob Agents. 2005;25(1):11–25.
   PubMed Web of Science ®Google Scholar
• Antonic V, Stojadinovic A, Zhang B, et al. Pseudomonas aeruginosa induces pigment production and enhances virulence in a white phenotypic variant of Staphylococcus aureus. Infect Drug Resist. 2013;6:175–186.
   PubMedGoogle Scholar
• Mlynarcik P, Kolar M. Molecular mechanisms of polymyxin resistance and detection of mcr genes. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019;163(1):28–38.
   PubMed Web of Science ®Google Scholar
• Abachin E, Poyart C, Pellegrini E, et al. Formation of D-alanyl-lipoteichoic acid is required for adhesion and virulence of Listeria monocytogenes. Mol Microbiol. 2002;43(1):1–14.
   PubMed Web of Science ®Google Scholar
• Gregoire N, Aranzana-Climent V, Magreault S, et al. Clinical Pharmacokinetics and Pharmacodynamics of colistin. Clin Pharmacokinet. 2017;56(12):1441–1460.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.
   PubMed Web of Science ®Google Scholar
• Rhouma M, Beaudry F, Theriault W, et al. Colistin in Pig production: chemistry, mechanism of antibacterial action, microbial resistance emergence, and one health perspectives. Front Microbiol. 2016;7:1789.
   PubMed Web of Science ®Google Scholar
• Poirel L, Jayol A, Nordmann P. Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev. 2017;30(2):557–596.
   PubMed Web of Science ®Google Scholar
• Yu Z, Qin W, Lin J, et al. Antibacterial mechanisms of polymyxin and bacterial resistance. Biomed Res Int. 2015;2015:679109.
   Web of Science ®Google Scholar
• Yu Z, Zhu Y, Fu J, et al. Enhanced NADH metabolism involves colistin-induced killing of Bacillus subtilis and Paenibacillus polymyxa. Molecules. 2019;24(3):387.
   PubMed Web of Science ®Google Scholar
• Mogi T, Murase Y, Mori M, et al. Polymyxin B identified as an inhibitor of alternative NADH dehydrogenase and malate: quinone oxidoreductase from the Gram-positive bacterium Mycobacterium smegmatis. J Biochem. 2009;146(4):491–499.
   PubMed Web of Science ®Google Scholar
• Deris ZZ, Akter J, Sivanesan S, et al. A secondary mode of action of polymyxins against Gram-negative bacteria involves the inhibition of NADH-quinone oxidoreductase activity. J Antibiot. 2014;67(2):147–151.
   PubMed Web of Science ®Google Scholar
• Martis N, Leroy S, Blanc V. Colistin in multi-drug resistant Pseudomonas aeruginosa blood-stream infections: a narrative review for the clinician. J Infect. 2014;69(1):1–12.
   PubMed Web of Science ®Google Scholar
• Grau-Campistany A, Manresa A, Pujol M, et al. Tryptophan-containing lipopeptide antibiotics derived from polymyxin B with activity against Gram positive and Gram negative bacteria. Biochim Biophys Acta. 2016;1858(2):333–343.
   PubMed Web of Science ®Google Scholar
• Domalaon R, Berry L, Tays Q, et al. Development of dilipid polymyxins: Investigation on the effect of hydrophobicity through its fatty acyl component. Bioorg Chem. 2018;80:639–648.
   PubMed Web of Science ®Google Scholar
• Rose F, Heuer KU, Sibelius U, et al. Targeting lipopolysaccharides by the nontoxic polymyxin B nonapeptide sensitizes resistant Escherichia coli to the bactericidal effect of human neutrophils. J Infect Dis. 2000;182(1):191–199.
   PubMed Web of Science ®Google Scholar
• Vaara M. Polymyxin derivatives that sensitize Gram-negative bacteria to other antibiotics. Molecules. 2019;24(2):249.
   PubMed Web of Science ®Google Scholar
• MacNair CR, Stokes JM, Carfrae LA, et al. Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics. Nat Commun. 2018;9(1):458.
   PubMed Web of Science ®Google Scholar
• Hood MI, Becker KW, Roux CM, et al. . genetic determinants of intrinsic colistin tolerance in Acinetobacter baumannii. Infect Immun. 2013;81(2):542–551.
   PubMed Web of Science ®Google Scholar
• Liu YY, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):161–168.
   PubMed Web of Science ®Google Scholar
• Lima T, Domingues S, Da Silva GJ. Plasmid-mediated colistin resistance in Salmonella enterica: A review. Microorganisms. 2019;7(2):55.
   PubMed Web of Science ®Google Scholar
• Cannatelli A, Giani T, D'Andrea MM, et al. Mgrb inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin. Antimicrob Agents Chemother. 2014;58(10):5696–5703.
   PubMed Web of Science ®Google Scholar
• Lippa AM, Goulian M. Feedback inhibition in the PhoQ/PhoP signaling system by a membrane peptide. PLoS Genet. 2009;5(12):e1000788.
   PubMed Web of Science ®Google Scholar
• Cheng YH, Lin TL, Lin YT, et al. Amino acid substitutions of CrrB responsible for resistance to colistin through CrrC in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2016;60(6):3709–3716.
   PubMed Web of Science ®Google Scholar
• Perez F, El Chakhtoura NG, Yasmin M, et al. Polymyxins: To Combine or Not to Combine? Antibiotics. 2019;8(2):38.
   Web of Science ®Google Scholar
• Fresno S, Jimenez N, Izquierdo L, et al. The ionic interaction of Klebsiella pneumoniae K2 capsule and core lipopolysaccharide. Microbiology. 2006;152(Pt 6):1807–1818.
   PubMed Web of Science ®Google Scholar
• Lima WG, Alves MC, Cruz WS, et al. Chromosomally encoded and plasmid-mediated polymyxins resistance in Acinetobacter baumannii: a huge public health threat. Eur J Clin Microbiol Infect Dis. 2018;37(6):1009–1019.
   PubMed Web of Science ®Google Scholar
• Feng Y. Transferability of MCR-1/2 polymyxin resistance: complex dissemination and genetic mechanism. ACS Infect Dis. 2018;4(3):291–300.
   PubMed Web of Science ®Google Scholar
• Snitkin ES, Zelazny AM, Gupta J, et al. Genomic insights into the fate of colistin resistance and Acinetobacter baumannii during patient treatment. Genome Res. 2013;23(7):1155–1162.
   PubMed Web of Science ®Google Scholar
• Adams MD, Nickel GC, Bajaksouzian S, et al. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob Agents Chemother. 2009;53(9):3628–3634.
   PubMed Web of Science ®Google Scholar
• Cheah SE, Johnson MD, Zhu Y, et al. Polymyxin resistance in Acinetobacter baumannii: genetic mutations and transcriptomic changes in response to clinically relevant dosage regimens. Sci Rep. 2016;6:26233.
   PubMed Web of Science ®Google Scholar
• Moffatt JH, Harper M, Harrison P, et al. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob Agents Chemother. 2010;54(12):4971–4977.
   PubMed Web of Science ®Google Scholar
• Bojkovic J, Richie DL, Six DA, et al. Characterization of an Acinetobacter baumannii lptD deletion strain: permeability defects and response to inhibition of lipopolysaccharide and fatty acid biosynthesis. J Bacteriol. 2015;198(4):731–741.
   PubMed Web of Science ®Google Scholar
• Whitfield C, Trent MS. Biosynthesis and export of bacterial lipopolysaccharides. Annu Rev Biochem. 2014;83:99–128.
   PubMed Web of Science ®Google Scholar
• Thi Khanh NN, Riordan DW, Do Hoang NT, et al. The induction and identification of novel colistin resistance mutations in Acinetobacter baumannii and their implications. Sci Rep. 2016;6:28291.
   PubMed Web of Science ®Google Scholar
• Lin MF, Lin YY, Lan CY. Contribution of EmrAB efflux pumps to colistin resistance in Acinetobacter baumannii. J Microbiol. 2017;55(2):130–136.
   PubMed Web of Science ®Google Scholar
• Trebosc V, Gartenmann S, Totzl M, et al. Dissecting colistin resistance mechanisms in extensively drug-resistant Acinetobacter baumannii clinical isolates. MBio. 2019;10(4):e01083-19.
   PubMed Web of Science ®Google Scholar
• Muller C, Plesiat P, Jeannot K. A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and beta-lactams in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2011;55(3):1211–1221.
   PubMed Web of Science ®Google Scholar
• Miller AK, Brannon MK, Stevens L, et al. Phoq mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients. Antimicrob Agents Chemother. 2011;55(12):5761–5769.
   PubMed Web of Science ®Google Scholar
• Zhao F, Feng Y, Lu X, et al. Incp plasmid carrying colistin resistance gene mcr-1 in Klebsiella pneumoniae from hospital sewage. Antimicrob Agents Chemother. 2017;61(2):e02229-16.
   PubMed Web of Science ®Google Scholar
• Lee JY, Na IY, Park YK, et al. Genomic variations between colistin-susceptible and -resistant Pseudomonas aeruginosa clinical isolates and their effects on colistin resistance. J Antimicrob Chemother. 2014;69(5):1248–1256.
   PubMed Web of Science ®Google Scholar
• Morey P, Viadas C, Euba B, et al. Relative contributions of lipooligosaccharide inner and outer core modifications to nontypeable Haemophilus influenzae pathogenesis. Infect Immun. 2013;81(11):4100–4111.
   PubMed Web of Science ®Google Scholar
• Quiroga C, Nastro M, Di CJ. Current scenario of plasmid-mediated colistin resistance in Latin America. Rev Argent Microbiol. 2019;51(1):93–100.
   PubMed Web of Science ®Google Scholar
• Nikaido H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev. 2003;67(4):593–656.
   PubMed Web of Science ®Google Scholar
• Olaitan AO, Morand S, Rolain JM. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol. 2014;5: 643.
   PubMed Web of Science ®Google Scholar
• Aghapour Z, Gholizadeh P, Ganbarov K, et al. Molecular mechanisms related to colistin resistance in Enterobacteriaceae. Infect Drug Resist. 2019;12:965–975.
   PubMed Web of Science ®Google Scholar
• Cannatelli A, D'Andrea MM, Giani T, et al. In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator. Antimicrob Agents Chemother. 2013;57(11):5521–5526.
   PubMed Web of Science ®Google Scholar
• Mills G, Dumigan A, Kidd T, et al. Identification and characterization of two Klebsiella pneumoniae lpxL lipid A late Acyltransferases and their role in Virulence. Infect Immun. 2017;85(9):e00068-17.
   PubMed Web of Science ®Google Scholar
• Gefen O, Chekol B, Strahilevitz J, et al. TDtest: easy detection of bacterial tolerance and persistence in clinical isolates by a modified disk-diffusion assay. Sci Rep. 2017;7:41284.
   PubMed Web of Science ®Google Scholar
• Herrera CM, Hankins JV, Trent MS. Activation of PmrA inhibits LpxT-dependent phosphorylation of lipid A promoting resistance to antimicrobial peptides. Mol Microbiol. 2010;76(6):1444–1460.
   PubMed Web of Science ®Google Scholar
• Trimble MJ, Mlynarcik P, Kolar M, et al. Polymyxin: alternative mechanisms of action and resistance. Cold Spring Harb Perspect Med. 2016;6(10):a025288.
   PubMed Web of Science ®Google Scholar
• Da Silva GJ, Domingues S. Interplay between colistin resistance, virulence and fitness in Acinetobacter baumannii. Antibiotics. 2017;6(4):28.
   Web of Science ®Google Scholar
• Chambers JR, Sauer K. The MerR-like regulator BrlR impairs Pseudomonas aeruginosa biofilm tolerance to colistin by repressing PhoPQ. J Bacteriol. 2013;195(20):4678–4688.
   PubMed Web of Science ®Google Scholar
• Haenni M, Poirel L, Kieffer N, et al. Co-occurrence of extended spectrum beta lactamase and MCR-1 encoding genes on plasmids. Lancet Infect Dis. 2016;16(3):281–282.
   PubMed Web of Science ®Google Scholar
• Wang Q, Sun J, Li J, et al. Expanding landscapes of the diversified mcr-1-bearing plasmid reservoirs. Microbiome. 2017;5(1):70.
   PubMed Web of Science ®Google Scholar
• Wang Y, Hu Y, Cao J, et al. Antibiotic resistance gene reservoir in live poultry markets. J Infect. 2019;78(6):445–453.
   PubMed Web of Science ®Google Scholar
• Yang RS, Feng Y, Lv XY, et al. Emergence of NDM-5- and MCR-1-producing Escherichia coli Clones ST648 and ST156 from a single Muscovy Duck (Cairina moschata). Antimicrob Agents Chemother. 2016;60(11):6899–6902.
   PubMed Web of Science ®Google Scholar
• Gao R, Hu Y, Li Z, et al. Dissemination and mechanism for the MCR-1 colistin resistance. PLoS Pathog. 2016;12(11):e1005957.
   PubMed Web of Science ®Google Scholar
• Yang Q, Li M, Spiller OB, et al. Balancing mcr-1 expression and bacterial survival is a delicate equilibrium between essential cellular defence mechanisms. Nat Commun. 2017;8(1):2054.
   PubMed Web of Science ®Google Scholar
• AbuOun M, Stubberfield EJ, Duggett NA, et al. . mcr-1 and mcr-2 variant genes identified in Moraxella species isolated from pigs in Great Britain from 2014 to 2015. J Antimicrob Chemother. 2017;72(10):2745–2749.
   PubMed Web of Science ®Google Scholar
• Borowiak M, Fischer J, Hammerl JA, et al. Identification of a novel transposon-associated phosphoethanolamine transferase gene, mcr-5, conferring colistin resistance in d-tartrate fermenting Salmonella enterica subsp. enterica serovar Paratyphi B. J Antimicrob Chemother. 2017;72(12):3317–3324.
   PubMed Web of Science ®Google Scholar
• Carattoli A, Villa L, Feudi C, et al. Novel plasmid-mediated colistin resistance mcr-4 gene in Salmonella and Escherichia coli, Italy 2013, Spain and Belgium, 2015 to 2016. Euro Surveill. 2017;22(31):30589.
   PubMedGoogle Scholar
• Wang X, Wang Y, Zhou Y, et al. Emergence of a novel mobile colistin resistance gene, mcr-8, in NDM-producing Klebsiella pneumoniae. Emerg Microbes Infect. 2018;7(1):122.
   PubMed Web of Science ®Google Scholar
• Xavier BB, Lammens C, Ruhal R, et al. Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016. Euro Surveill. 2016;21(27):30280.
   Google Scholar
• Yang F, Shen C, Zheng X, et al. Plasmid-mediated colistin resistance gene mcr-1 in Escherichia coli and Klebsiella pneumoniae isolated from market retail fruits in Guangzhou, China. Infect Drug Resist. 2019;12:385–389.
   PubMed Web of Science ®Google Scholar
• Yang YQ, Li YX, Lei CW, et al. Novel plasmid-mediated colistin resistance gene mcr-7.1 in Klebsiella pneumoniae. J Antimicrob Chemother. 2018;73(7):1791–1795.
   PubMed Web of Science ®Google Scholar
• Yin W, Li H, Shen Y, et al. Novel plasmid-mediated colistin resistance gene mcr-3 in Escherichia coli. MBio. 2017;8(3):e00543-17.
   PubMed Web of Science ®Google Scholar
• Di P V, Arena F, Tascini C, et al. . mcr-1.2, a new mcr variant carried on a transferable plasmid from a colistin-resistant KPC carbapenemase-producing Klebsiella pneumoniae strain of sequence type 512. Antimicrob Agents Chemother. 2016;60(9):5612–5615.
   PubMed Web of Science ®Google Scholar
• Yang YQ, Li YX, Song T, et al. Colistin resistance gene mcr-1 and its variant in Escherichia coli isolates from chickens in China. Antimicrob Agents Chemother. 2017;61(5):e01204-16.
   PubMed Web of Science ®Google Scholar
• Zhao F, Feng Y, Lu X, et al. Remarkable diversity of Escherichia coli carrying mcr-1 from hospital sewage with the identification of two New mcr-1 variants. Front Microbiol. 2017;8:2094.
   PubMed Web of Science ®Google Scholar
• Tijet N, Faccone D, Rapoport M, et al. Molecular characteristics of mcr-1-carrying plasmids and new mcr-1 variant recovered from polyclonal clinical Escherichia coli from Argentina and Canada. PLoS One. 2017;12(7):e0180347.
   PubMed Web of Science ®Google Scholar
• Lu X, Hu Y, Luo M, et al. MCR-1.6, a new MCR variant carried by an IncP plasmid in a colistin-resistant Salmonella enterica serovar Typhimurium isolate from a healthy individual. Antimicrob Agents Chemother. 2017;61(5):e02632-16.
   PubMed Web of Science ®Google Scholar
• Manageiro V, Clemente L, Romao R, et al. Incx4 plasmid carrying the New mcr-1.9 gene variant in a CTX-M-8-producing Escherichia coli isolate recovered from swine. Front Microbiol. 2019;10:367.
   PubMed Web of Science ®Google Scholar
• Deshpande LM, Hubler C, Davis AP, et al. Updated prevalence of mcr-like genes among Escherichia coli and Klebsiella pneumoniae in the SENTRY program and characterization of mcr-1.11 variant. Antimicrob Agents Chemother. 2019;63(4):e02450-18.
   PubMed Web of Science ®Google Scholar
• Alba P, Leekitcharoenphon P, Franco A, et al. Molecular epidemiology of mcr-encoded colistin resistance in enterobacteriaceae from food-producing animals in Italy revealed through the EU harmonized antimicrobial resistance Monitoring. Front Microbiol. 2018;9:1217.
   PubMed Web of Science ®Google Scholar
• Ma F, Shen C, Zheng X, et al. Identification of a novel plasmid carries mcr-4.3 in Acinetobacter baumannii from China. Antimicrob Agents Chemother. 2019;63(6):e00133-19.
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhong LL, Srinivas S, et al. Spread of MCR-3 colistin resistance in China: An epidemiological, Genomic and Mechanistic study. EBioMedicine. 2018;34:139–157.
   PubMed Web of Science ®Google Scholar
• Carroll LM, Gaballa A, Guldimann C, et al. Identification of novel mobilized colistin resistance gene mcr-9 in a multidrug-resistant, colistin-susceptible Salmonella enterica Serotype Typhimurium isolate. MBio. 2019;10(3):e00853-19.
   PubMed Web of Science ®Google Scholar
• Litrup E, Kiil K, Hammerum AM, et al. Plasmid-borne colistin resistance gene mcr-3 in Salmonella isolates from human infections, Denmark, 2009–17. Euro Surveill. 2017;22(31):30587.
   PubMedGoogle Scholar
• Volland H, Dortet L, Bernabeu S, et al. Development and multicentric validation of a lateral flow immunoassay for rapid detection of MCR-1-producing enterobacteriaceae. J Clin Microbiol. 2019;57(5):e01454-18.
   PubMed Web of Science ®Google Scholar
• Zhang J, Chen L, Wang J, et al. Molecular detection of colistin resistance genes (mcr-1 to mcr-5) in human vaginal swabs. BMC Res Notes. 2018;11(1):143.
   PubMedGoogle Scholar
• Liu L, Feng Y, Zhang X, et al. New variant of mcr-3 in an extensively drug-resistant Escherichia coli clinical isolate carrying mcr-1 and blaNDM-5. Antimicrob Agents Chemother. 2017;61(12):e01757-17.
   PubMed Web of Science ®Google Scholar
• Bi Z, Berglund B, Sun Q, et al. Prevalence of the mcr-1 colistin resistance gene in extended-spectrum beta-lactamase-producing Escherichia coli from human faecal samples collected in 2012 in rural villages in Shandong Province, China. Int J Antimicrob Agents. 2017;49(4):493–497.
   PubMed Web of Science ®Google Scholar
• Novem V, Shui G, Wang D, et al. Structural and biological diversity of lipopolysaccharides from Burkholderia pseudomallei and Burkholderia thailandensis. Clin Vaccine Immunol. 2009;16(10):1420–1428.
   PubMed Web of Science ®Google Scholar
• Xu Y, Wei W, Lei S, et al. An evolutionarily conserved mechanism for intrinsic and transferable polymyxin resistance. MBio. 2018;9(2):e02317-17.
   PubMed Web of Science ®Google Scholar